Skip to main content
SpringerLink
Log in

Overview of Head and Neck Cancer

  • Chapter
Head and Neck Cancer

Part of the book series: Cancer Treatment and Research ((CTAR,volume 114))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1973 1998, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/publications/CSR1 973_1998/,2001.

    Google Scholar 

  2. McKaig RG, Baric RS, Olshan AF. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 1998; 20:250–65.

    Article  PubMed  CAS  Google Scholar 

  3. Silverman S. Oral Cancer. In: Silverman S, ed. Atlanta: The American Cancer Society, 1990.

    Google Scholar 

  4. Copper MP, Jovanovic A, Nauta JJ, et al. Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1995;121:157–60.

    PubMed  CAS  Google Scholar 

  5. Van der Riet P, Nawroz H, Hruban RH, et al. Frequent loss of chromosome 9p21 22 early in head and neck cancer progression. Cancer Res 1996; 56:2488–92.

    PubMed  Google Scholar 

  6. Somers K, Merrick MA, Lopez ME, Incognito LS, Schechter GL, Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res 1992; 52:5997–6000.

    PubMed  CAS  Google Scholar 

  7. Cooper JS, Pajak TF, Rubin P, et al. Second malgnancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 1989; 17:449–56.

    PubMed  CAS  Google Scholar 

  8. Forastiere A, Koch W, Trotti A, and Sidransky D. Head and neck cancer. N Engl J Med 2001; 345:1890.

    Article  PubMed  CAS  Google Scholar 

  9. Sankaranarayanan R, Mathew B, Jacob BJ, et al. Early findings from a communitybased, cluster randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer 2000; 88:664–73.

    Article  PubMed  CAS  Google Scholar 

  10. Dickens WJ, Cassisi NJ, Million RR, et al. Treatment results of early vocal cord carcinoma: A comparison of apples and oranges. Laryngoscope 1983; 93:216–219.

    PubMed  CAS  Google Scholar 

  11. Mendenhall MM, Hinerman RW, Stringer Sp, et al. Management of Early and Advanced Laryngeal Cancer: Current status of larynx preservation. Updates in Head and Neck Cancer 2001; 1:1–14.

    Google Scholar 

  12. Laramore GB, Scott CB, Al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup study 0034. Int J Radiat Oncol Biol Phys 1992; 23:705–713.

    PubMed  CAS  Google Scholar 

  13. Head and Neck Contracts Program. Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the head and neck contracts program. Cancer 1987; 60:301–311

    Google Scholar 

  14. Paccagnella A, Orlando A, Marchiori C, et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppodidi Studio SUI Tumori Della Testa E Del Collo. J Natl Cancer Inst 1994;86:265–272.

    PubMed  CAS  Google Scholar 

  15. Sanchiz F, Milla A, Tomer J, et al. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J Radiation Oncol Biol Phys 1990; 19:1347–1350

    CAS  Google Scholar 

  16. Merlano M, Vitale V, Rosso R, et al. Treatment of Advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 1992; 327:1115–1121

    Article  PubMed  CAS  Google Scholar 

  17. Fu KK, Pajak TF, Trotti A, et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionated and two variants of accelerated fractionation to standard fractionated radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiation Oncology Biol Phys 2000; 48:7–16.

    CAS  Google Scholar 

  18. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated

    Google Scholar 

  19. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Cancer Study Group. N Engl J Med 1991; 324:1685–1690.

    Google Scholar 

  20. Lefebvre, JL, Chevalier, D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for research of cancer phase II trial. J Natl Cancer Inst 1996; 88:890–899.

    PubMed  CAS  Google Scholar 

  21. Forastiere AA, Berkey B, Maor M, et al. Phase III trial to preserve the larynx: Induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone, Intergroup trial R91 11. Proc ASCO 2001; 20:abstract 4.

    Google Scholar 

  22. Kies MS, Haraf DJ, Rosen F, et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 2001; 19:1961–1969.

    PubMed  CAS  Google Scholar 

  23. Adelstein DJ, Lavertu P, Saxton JP et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 2000;88:876–883.

    Article  PubMed  CAS  Google Scholar 

  24. Brockstein B, Haraf DJ, Stenson K, et al. A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with gcsf support for patients with poor prognosis head and neck cancer. Annals of Oncology 2000;11:721–728

    Article  PubMed  CAS  Google Scholar 

  25. Brockstein BE, Vokes EE. Principles of Chemotherapy in the management of head and neck cancer. In: Bailey BJ, ed. Head and Neck Surgery-Otolaryngology, 3rd ed. Lippincott Williams and Wilkins. Philadelphia, 2001.

    Google Scholar 

  26. Al-Sarraf M, LeBlanc M, Shanker Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099. J Clin Oncol 1998; 16:1310–1317.

    PubMed  CAS  Google Scholar 

  27. Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11:570–9.

    PubMed  CAS  Google Scholar 

  28. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85:365–76.

    PubMed  CAS  Google Scholar 

  29. List MA, Siston A, Haraf D, et al. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol 1999; 17:1020–8.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Evanston Northwestern Healthcare, Evanston, IL

    Gregory Masters M.D. & Bruce Brockstein M.D.

  2. Robert H. Lurie Cancer Center of Northwestern University, Feiberg School of Medicine, Chicago, IL

    Gregory Masters M.D. & Bruce Brockstein M.D.

Authors
  1. Gregory Masters M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bruce Brockstein M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Evanston Northwestern Healthcare, Evanston, IL

    Brockstein Bruce M.D.  & Masters Gregory M.D.  & 

  2. Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL

    Brockstein Bruce M.D.  & Masters Gregory M.D.  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Kluwer Academic Publishers

About this chapter

Cite this chapter

Masters, G., Brockstein, B. (2004). Overview of Head and Neck Cancer. In: Bruce, B., Gregory, M. (eds) Head and Neck Cancer. Cancer Treatment and Research, vol 114. Springer, Boston, MA. https://doi.org/10.1007/0-306-48060-3_1

Download citation

  • DOI: https://doi.org/10.1007/0-306-48060-3_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4020-7336-6

  • Online ISBN: 978-0-306-48060-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation